UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 175

Sortiert nach

Irinotecan combined with bolus 5-fluorouracil and folinic acid Nordic schedule as first-line therapy in advanced colorectal cancer

Annals of oncology, 2002-12, Vol.13 (12), p.1868-1873

2002

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase II trial of irinotecan in combination with infusional or two different bolus 5-fluorouracil and folinic acid regimens as first-line therapy for advanced colorectal cancer

Annals of oncology, 2003-07, Vol.14 (7), p.1106-1114

2003

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II study of first-line irinotecan combined with 5-fluorouracil and folinic acid Mayo Clinic schedule in patients with advanced colorectal cancer

BMC cancer, 2004-07, Vol.4 (1), p.36-36, Article 36

2004

Link zum Volltext

Verfügbarkeit prüfen

Irinotecan combined or alternated with bolus 5-fluorouracil and folinic acid versus the Mayo Clinic regimen in the first-line therapy of advanced colorectal cancer

Oncology reports, 2005-04, Vol.13 (4), p.681

2005

Link zum Volltext

Verfügbarkeit prüfen

CPT-11 in combination with capecitabine as first line chemotherapy for metastatic colorectal cancer (MCRC): preliminary results of a phase I/II study

European journal of cancer (1990), 2001-04, Vol.37, p.S296-S296

2001

Link zum Volltext

Verfügbarkeit prüfen

CPT-11 combined or alternated with 5 fluoruracil/folinic acid (5-FU/FA) vs mayo clinic regimen in first line therapy of advanced colorectal cancer (ACRC)

Gastroenterology (New York, N.Y. 1943), 2001-04, Vol.120 (5), p.A611-A611

2001

Link zum Volltext

Verfügbarkeit prüfen

Phase I of CPT-11 (CAMPTO®) combined with 5-FU/folinic acid (FA) nordic schedule in first line metastatic colorectal cancer (CRC)

European journal of cancer (1990), 1999-09, Vol.35, p.S79-S79

1999

Link zum Volltext

Verfügbarkeit prüfen

CPT-11 combined or alternated with 5 fluoruracil/folinic acid (5-FU/FA) vs mayo clinic regimen in first line therapy of advanced colorectal cancer (ACRC)

Gastroenterology (New York, N.Y. 1943), 2001-04, Vol.120 (5), p.A611-A611

2001

Link zum Volltext

Verfügbarkeit prüfen

CPT-11 combined with 5 fluorouracil bolus (B)/folinic acid (5FU/FA) nordic schedule as front line therapy in patients (pts) with advanced colorectal cancer (CRC)

European journal of cancer (1990), 2001-04, Vol.37, p.S305-S306

2001

Link zum Volltext

Verfügbarkeit prüfen

CPT-11 and 5 fluorouracil/folinic acid (5-FU/FA) mayo clinic regimen in advanced colorectal cancer (CRC) as front line therapy: a phase I/II study

European journal of cancer (1990), 2001-04, Vol.37, p.S306-S306

2001

Link zum Volltext

Verfügbarkeit prüfen

Extensive clinical experience with Taxotere® (T) is 1st and 2nd line treatment (tt) at 100 mg/m2 in locally advanced (LA) or metastatic breast cancer (MBC)

European journal of cancer (1990), 1999-09, Vol.35, p.S320

1999

Link zum Volltext

Verfügbarkeit prüfen

Taxotere® (T) and doxorubicin (D) combination: a phase II South American study in first line treatment (tt) of metastatic breast cancer (MBC)

European journal of cancer (1990), 1999-09, Vol.35, p.S329-S329

1999

Link zum Volltext

Verfügbarkeit prüfen

Extensive clinical experience with Taxotere® (T) is 1st and 2nd line treatment (tt) at 100 mg/m 2 in locally advanced (LA) or metastatic breast cancer (MBC)

European journal of cancer (1990), 1999, Vol.35, p.S320-S320

1999

Link zum Volltext

Verfügbarkeit prüfen

CAMPTO® (CPT-11) combined with different schedules of bolus 5-FU in 1st line treatment of metastatic colorectal cancer

European journal of cancer (1990), 1999-09, Vol.35, p.S79-S79

1999

Link zum Volltext

Verfügbarkeit prüfen

Comment vous êtes-vous connus? 2. Code patent, code latent in Pouvoirs d'école. 2

Actes de la recherche en sciences sociales, 1987 (70), p.87-92

1987

Link zum Volltext

Verfügbarkeit prüfen

A phase I/II of CPT-11 combined with 5-fluorouracil (5FU)/folinic acid (FA) Nordic schedule as first line therapy in patients (pts) with metastatic colorectal cancer (MCRC)

ANNALS OF ONCOLOGY, 2000, Vol.11, p.47

2000

Link zum Volltext

Verfügbarkeit prüfen

THE EFFECTS OF MIDAZOLAM ON TRANSIENT INSOMNIA

Clinical neuropharmacology, 1992, Vol.15, p.78

1992

Link zum Volltext

Verfügbarkeit prüfen

Design, processing, and characterization of an optical core‐bioactive clad phosphate fiber for biomedical applications

Journal of the American Ceramic Society, 2019-11, Vol.102 (11), p.6882-6892

2019

Link zum Volltext

Verfügbarkeit prüfen

Development of Far-Infrared-Transmitting Te Based Glasses Suitable for Carbon Dioxide Detection and Space Optics

Advanced materials (Weinheim), 2007-11, Vol.19 (22), p.3796-3800

2007

Link zum Volltext

Verfügbarkeit prüfen

Systematic Review of Return to Work After Mild Traumatic Brain Injury: Results of the International Collaboration on Mild Traumatic Brain Injury Prognosis

Archives of physical medicine and rehabilitation, 2014-03, Vol.95 (3), p.S201-S209

2014

Link zum Volltext

Verfügbarkeit prüfen

Nonsurgical Interventions After Mild Traumatic Brain Injury: A Systematic Review. Results of the International Collaboration on Mild Traumatic Brain Injury Prognosis

Archives of physical medicine and rehabilitation, 2014-03, Vol.95 (3), p.S257-S264

2014

Link zum Volltext

Verfügbarkeit prüfen

Preventability of early vs. late readmissions in an academic medical center

PloS one, 2017-06, Vol.12 (6), p.e0178718-e0178718

2017

Link zum Volltext

Verfügbarkeit prüfen

Influence of API physico-chemical properties on amorphization capacity of several mesoporous silica loading methods

International journal of pharmaceutics, 2022-02, Vol.613, p.121372-121372, Article 121372

2022

Link zum Volltext

Verfügbarkeit prüfen

Systematic Review of Prognosis and Return to Play After Sport Concussion: Results of the International Collaboration on Mild Traumatic Brain Injury Prognosis

Archives of physical medicine and rehabilitation, 2014-03, Vol.95 (3), p.S210-S229

2014

Link zum Volltext

Verfügbarkeit prüfen

Co-doped Dy3+ and Pr3+ Ga5Ge20Sb10S65 fibers for mid-infrared broad emission

Optics letters, 2018-06, Vol.43 (12), p.2893-2896

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 175

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(158)
Mit Volltextzugriff
(161)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(102)
Chemical Sciences
(51)
Technology
(49)
Physical Sciences
(46)
Life Sciences & Biomedicine
(39)
Humans
(38)
Material Chemistry
(36)
Materials Science
(32)
Chemistry
(27)
Materials Science, Multidisciplinary
(24)
Female
(23)
Glass
(23)
Optics
(21)
Physics
(21)
Male
(18)
Biological And Medical Sciences
(16)
Chalcogenides
(15)
Materials Science, Ceramics
(15)
Adult
(13)
Middle Aged
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Irinotecan combined with bolus 5-fluorouracil and folinic acid Nordic schedule as first-line therapy in advanced colorectal cancer

A randomized phase II trial of irinotecan in combination with infusional or two different bolus 5-fluorouracil and folinic acid regimens as first-line therapy for advanced colorectal cancer

Phase I/II study of first-line irinotecan combined with 5-fluorouracil and folinic acid Mayo Clinic schedule in patients with advanced colorectal cancer

Irinotecan combined or alternated with bolus 5-fluorouracil and folinic acid versus the Mayo Clinic regimen in the first-line therapy of advanced colorectal cancer

CPT-11 in combination with capecitabine as first line chemotherapy for metastatic colorectal cancer (MCRC): preliminary results of a phase I/II study

CPT-11 combined or alternated with 5 fluoruracil/folinic acid (5-FU/FA) vs mayo clinic regimen in first line therapy of advanced colorectal cancer (ACRC)

Phase I of CPT-11 (CAMPTO®) combined with 5-FU/folinic acid (FA) nordic schedule in first line metastatic colorectal cancer (CRC)

CPT-11 combined or alternated with 5 fluoruracil/folinic acid (5-FU/FA) vs mayo clinic regimen in first line therapy of advanced colorectal cancer (ACRC)

CPT-11 combined with 5 fluorouracil bolus (B)/folinic acid (5FU/FA) nordic schedule as front line therapy in patients (pts) with advanced colorectal cancer (CRC)

CPT-11 and 5 fluorouracil/folinic acid (5-FU/FA) mayo clinic regimen in advanced colorectal cancer (CRC) as front line therapy: a phase I/II study

Extensive clinical experience with Taxotere® (T) is 1st and 2nd line treatment (tt) at 100 mg/m2 in locally advanced (LA) or metastatic breast cancer (MBC)

Taxotere® (T) and doxorubicin (D) combination: a phase II South American study in first line treatment (tt) of metastatic breast cancer (MBC)

Extensive clinical experience with Taxotere® (T) is 1st and 2nd line treatment (tt) at 100 mg/m 2 in locally advanced (LA) or metastatic breast cancer (MBC)

CAMPTO® (CPT-11) combined with different schedules of bolus 5-FU in 1st line treatment of metastatic colorectal cancer

Comment vous êtes-vous connus? 2. Code patent, code latent in Pouvoirs d'école. 2

A phase I/II of CPT-11 combined with 5-fluorouracil (5FU)/folinic acid (FA) Nordic schedule as first line therapy in patients (pts) with metastatic colorectal cancer (MCRC)

THE EFFECTS OF MIDAZOLAM ON TRANSIENT INSOMNIA

Design, processing, and characterization of an optical core‐bioactive clad phosphate fiber for biomedical applications

Development of Far-Infrared-Transmitting Te Based Glasses Suitable for Carbon Dioxide Detection and Space Optics

Systematic Review of Return to Work After Mild Traumatic Brain Injury: Results of the International Collaboration on Mild Traumatic Brain Injury Prognosis

Nonsurgical Interventions After Mild Traumatic Brain Injury: A Systematic Review. Results of the International Collaboration on Mild Traumatic Brain Injury Prognosis

Preventability of early vs. late readmissions in an academic medical center

Influence of API physico-chemical properties on amorphization capacity of several mesoporous silica loading methods

Systematic Review of Prognosis and Return to Play After Sport Concussion: Results of the International Collaboration on Mild Traumatic Brain Injury Prognosis

Co-doped Dy3+ and Pr3+ Ga5Ge20Sb10S65 fibers for mid-infrared broad emission

Suchergebnisse filtern